Novel cell sorting
Ended Purchase Order Awarded Last action
- Contract number
- HT942523P0004
- Awardee
-
Eitr Biologics, Inc. UEI HX49LZLY32G5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,105,767
Award facts
- Opportunity
-
- Sorting of peripheral blood mononuclear cells (PBMCs) from Venezuelan Equine Encephalitis Virus (VEEV) survivors for The U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Solicitation · W81XWH22R0089 · Posted Aug 16, 2022
- Contract value 66% obligated
-
- $1,105,766.88 Current, with exercised options
- $1,665,253.80 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $50,686 | |
| Funding Only Action | $226,332 | |
| Exercise an Option | $277,018 | |
| Original award | $551,731 |
About this award
The Defense Health Agency awarded a $1,665,253.80 firm-fixed-price purchase order to Eitr Biologics, Inc. for novel cell sorting services. The contract is for sorting peripheral blood mononuclear cells from Venezuelan Equine Encephalitis Virus (VEEV) survivors to discover and produce monoclonal antibodies for in-vitro and in-vivo assessment against the virus. This award is not set aside. Eitr Biologics is a for-profit biotechnology company that specializes in developing innovative medical countermeasures, including antibody-based platforms and nanotherapeutics, for viral threats. The company has an Indefinite Delivery Vehicle (IDV) contract with the Defense Health Agency for developing novel nanotherapeutics to combat pneumonic plague, under which this award falls. Eitr Biologics has received multiple previous awards from the Defense Health Agency, Centers for Disease Control and Prevention, and National Institutes of Health for its expertise in antibody discovery, cell sorting, and nanotherapeutic development.
Quick answers
Who was awarded contract HT942523P0004?
HT942523P0004 was awarded to Eitr Biologics, Inc. by Defense Health Agency (Department of Defense) on November 28, 2022.
How much is contract HT942523P0004 worth?
The government has obligated $1,105,767 on HT942523P0004. Its potential value, with all options, is $1,665,254.
Was contract HT942523P0004 competed?
The extent of competition for HT942523P0004 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award